MY162183A - Probiotic composition for nutraceutical product - Google Patents

Probiotic composition for nutraceutical product

Info

Publication number
MY162183A
MY162183A MYPI20097032A MYPI20097032A MY162183A MY 162183 A MY162183 A MY 162183A MY PI20097032 A MYPI20097032 A MY PI20097032A MY PI20097032 A MYPI20097032 A MY PI20097032A MY 162183 A MY162183 A MY 162183A
Authority
MY
Malaysia
Prior art keywords
present
nutraceutical product
probiotic
relates
probiotic composition
Prior art date
Application number
MYPI20097032A
Inventor
Hooi Ling Foo
Teck Chwen Loh
Abdul Rahim Raha
Yin Sze Lim
Original Assignee
Univ Putra Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Putra Malaysia filed Critical Univ Putra Malaysia
Priority to MYPI20097032A priority Critical patent/MY162183A/en
Priority to PCT/MY2010/000306 priority patent/WO2011068398A1/en
Publication of MY162183A publication Critical patent/MY162183A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/25Lactobacillus plantarum
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

THE PRESENT INVENTION RELATES A NATURALLY OCCURRING SOURCE OF METABOLITES PRODUCED BY A PROBIOTIC BACTERIAL SPP AND A METHOD OF USING THE PROBIOTIC AS A DIETARY SUPPLEMENT. ALSO, THE PRESENT INVENTION RELATES TO NUTRACEUTICAL PRODUCT (S) INCLUDING BACTERIOCINS AND ORGANIC ACIDS, SUCH AS FORMIC, ACETIC ACID AND LACTIC ACID. THE PRESENT INVENTION ALSO HAS THE ABILITY TO INHIBIT VARIOUS FOOD-BORNE PATHOGENS AND ALSO OFFERS HEALTH PROMOTING EFFECT OF REDUCTION IN SERUM CHOLESTEROL LEVEL IS ANOTHER ASPECT OF THE PRESENT INVENTION.
MYPI20097032A 2009-12-01 2009-12-01 Probiotic composition for nutraceutical product MY162183A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MYPI20097032A MY162183A (en) 2009-12-01 2009-12-01 Probiotic composition for nutraceutical product
PCT/MY2010/000306 WO2011068398A1 (en) 2009-12-01 2010-11-29 Probiotic composition obtained from lactobacillus plantarum strains ul4, tl1, rs5, r111, rg14 or combinations thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20097032A MY162183A (en) 2009-12-01 2009-12-01 Probiotic composition for nutraceutical product

Publications (1)

Publication Number Publication Date
MY162183A true MY162183A (en) 2017-05-31

Family

ID=44115124

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20097032A MY162183A (en) 2009-12-01 2009-12-01 Probiotic composition for nutraceutical product

Country Status (2)

Country Link
MY (1) MY162183A (en)
WO (1) WO2011068398A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017180501A1 (en) 2016-04-11 2017-10-19 President And Fellows Of Harvard College Probiotic formulations for improving athletic performance
MA49010B1 (en) 2017-06-14 2020-11-30 4D Pharma Res Ltd Compositions comprising a bacterial strain of the genus megasphaera and their uses
LT3600363T (en) 2017-06-14 2021-02-10 4D Pharma Research Limited Compositions comprising bacterial strains
CN111067922A (en) * 2018-10-19 2020-04-28 临床营养国际(马来西亚)私人有限公司 Compound for delaying signs of aging of bones and muscles
CN111057661A (en) * 2019-11-19 2020-04-24 浙江圣达生物药业股份有限公司 25-hydroxy vitamin D3Production strain and screening method and application thereof
US20230112367A1 (en) * 2020-03-13 2023-04-13 Fitbiomics Inc. Probiotic compositions for improving human health and athletic performance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0918470A2 (en) * 2009-04-09 2016-06-14 Univ Putra Malaysia Upm biologically pure culture of a strain of probiotic bacteria, animal feed, animal feed formulation, process for promoting growth and / or feed conversion in monogastric or non-ruminant animal, and use of animal feed
MY158907A (en) * 2009-08-10 2016-11-30 Univ Putra Malaysia Upm Metabolites in animal feed

Also Published As

Publication number Publication date
WO2011068398A1 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
MX2013011626A (en) Synergistic antimicrobial effect.
MY162183A (en) Probiotic composition for nutraceutical product
WO2011103123A3 (en) Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
SG138520A1 (en) Tripentyl citrates and their use
WO2013026033A3 (en) Strains and methods useful for mycotoxins
PE20121406A1 (en) LACTOBACILLUS PLANTARUM STRAINS AS HYPOCHOLESTEROLEMIC AGENTS
UA100706C2 (en) Ruminant milk fat with reduced saturated fatty acids content and process for its production
SI2056681T1 (en) Homofermented products
BR112014030434A2 (en) non-therapeutic method; use of a protein; nutritional composition; and use of nutritional composition
MX2011012910A (en) Process for manufacturing of a fermented dairy product.
EP1941892A3 (en) Anti-allergy lactic acid bacteria
DK2062968T3 (en) BACKGROUND STREAMS WITH ANTI-ALLERGIC ACTIVITY, AND BEVERAGES, FOOD AND ANTI-ALLERGY PRODUCTS INCLUDING CELLS
WO2011162523A3 (en) Composition for preventing or treating osteoporosis, containing ssangwhatang or lactobacillus fermented product thereof
UA108602C2 (en) Bacteria that produce sialic acid
NZ612586A (en) Food containing milk ceramide, and process for production thereof
NZ721239A (en) Fermented flavoring system derived from greek yogurt processing
MY174494A (en) Method for inhibiting pathogens using a nutritional composition
MX2012000012A (en) Pasta product having reduced sodium anti-boil-over composition with enhanced cheese flavor notes.
WO2013084052A8 (en) Vitamin b12 producing lactobacillus reuteri strains
PT2477503E (en) Process for preparing a pasteurised and fermented dairy product supplemented with calcium and vitamin d
MX2014001767A (en) Methods for ameliorating symptoms or conditions caused by stress.
MX2011007222A (en) Nutritional composition for infants.
BR112014004123A2 (en) microorganisms of the xylanisolvens bacteroid species
WO2013046031A3 (en) Lactococcus lactis strains, and bacterial preparations thereof, for the production of bioactive peptides having anti-hypertensive and cholesterol-lowering effects in mammals; nutritional and therapeutic products produced therefrom
GR1008378B (en) Functional table olives fermented with lactic acid bacteria exhibiting probiotic properties